Zealand Pharma A/s Stock
€52.90
Your prediction
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | -3.590% | -3.220% | -3.502% | -46.727% | -17.318% | 86.006% | - |
| Immunic Inc. | 4.470% | 48.654% | 32.363% | -15.519% | 79.767% | -58.452% | -95.506% |
| Ocuphire Pharma Inc. | 5.060% | 20.669% | 74.743% | 183.272% | 82.224% | -12.379% | - |
| Actinium Pharmaceuticals Inc. | 3.250% | -3.478% | -18.312% | -11.158% | -21.831% | -92.196% | -87.586% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big


